- $137.53bn
- $182.62bn
- $63.63bn
- 98
- 83
- 77
- 98
Pfizer Inc - U.S. Patent and Trademark Office Accepts Pfizers Reissue Applicati
AnnouncementPfizer Inc - Statement re : Court Ruling
AnnouncementPfizer Inc - Regulatory Approval
AnnouncementPfizer Inc Pfizer and DNDi Advancing International Research Efforts In The Fight
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc - Pfizer Webcast Announcement
AnnouncementPfizer Inc - Earthquake Relief
AnnouncementPfizer Inc - Pfizer Announces Launch of Generic Amlodipine Besylate Product by G
AnnouncementPfizer Inc Pfizer Reports Third-Quarter 2009
AnnouncementPfizer Inc European Commission Approves New Intravenous Formulation Of Pfizers
AnnouncementPfizer Inc - Pfizers Novel HIV/AIDS Treatment Selzentry(TM) (Maraviroc) Demonst
AnnouncementPfizer Inc - Pfizer to Present Data on New Approaches to Pain and Inflammation T
AnnouncementPfizer Inc - Pfizer Declares a 32-Cent Fourth-Quarter 2008 Dividend
AnnouncementPfizer Inc - Federal Court in Canada Upholds Pfizers Norvasc Patent
AnnouncementPfizer Announces New $5 Billion Share Repurchase P
AnnouncementNews
AnnouncementPfizer Inc - Response to: Pfizer Lipitor UK Patent Decision
AnnouncementPfizer Inc - Pfizer to Present New Lipitor Data, Including Results from Three La
Announcement